Chat with us, powered by LiveChat

Press Release

Saama Challenges Analytics Industry to Guarantee Data Platforms to Help Accelerate Drug Development

Company Leads Call-to-Action by Issuing Saama Product Guarantee on Clinical Trials Day CAMPBELL, CA – (May 20, 2019) – Saama Technologies, Inc. (“Saama”), a leading clinical data analytics company, issued a call-to-action on Clinical Trials Day urging the analytics industry to commit to timely deployment of solutions for biopharmaceutical companies and the elimination of launch…

Read More

Saama Closes $40 Million Financing with Perceptive Advisors to Drive Disruption in Clinical Analytics and Drug Development

CAMPBELL, CA – (March 25, 2019) – Saama Technologies, Inc. (“Saama”), a leading clinical data analytics platform firm, announced that it has closed a $40 million financing with Perceptive Advisors. The new funding will be used to support the expansion of Saama’s Life Science Analytics Cloud (LSAC), an AI-powered platform disrupting the planning, designing and…

Read More

Saama Announced as a Finalist in Clinical Trial Process Innovation Category for 2019 Clinical & Research Excellence Awards

CAMPBELL, CA – (February 25, 2019) – Saama Technologies, Inc., a leading data analytics company, has been named a finalist in the Clinical Trial Process Innovation category for the 2019 Clinical & Research Excellence (CARE) Awards, which recognize outstanding work across the global clinical research enterprise. Saama was selected as a CARE Awards finalist in…

Read More

Saama Unveils New Capabilities for Award-Winning Life Science Analytics Cloud at SCOPE

CAMPBELL, CA – (February 18, 2019) – Saama Technologies, Inc., a leading data analytics company, today unveiled three new, machine learning-based capabilities that extend the existing functionality of its award-winning Life Science Analytics Cloud (LSAC). Saama announced the addition of these state-of-the-art programs infused with artificial intelligence (AI) — Virtual Assistant/AI, Operational and Financial Risk…

Read More

Saama Partners With The Leukemia & Lymphoma Society to Advance Study Operations for the Beat AML Master Trial to Provide Clinical Data Analytics

CAMPBELL, CA – (February 18, 2019) – Saama Technologies, Inc., a leading data analytics company, announced a new partnership with The Leukemia & Lymphoma Society (LLS), the world’s largest nonprofit dedicated to fighting blood cancers, to accelerate the development of novel acute myeloid leukemia (AML) therapies through its unprecedented Beat AML® Master Clinical Trial. LLS…

Read More

Clinical Epidemiologist, Mathematician, Open Science & Blockchain Enthusiast Dr. Mehdi Benchoufi Joins Saama Advisory Board

CAMPBELL, CA — (June 18, 2018) – Saama Technologies, Inc., a leading big data and advanced analytics solutions company, today announced that Mehdi Benchoufi, M.D., Assistant Professor in the Clinical Epidemiology Center at Hôtel-Dieu Hospital, University Paris Descartes, has joined its Board of Advisors (BOA). Dr. Benchoufi focuses on interfaces between clinical research and open technologies, with…

Read More

Saama Launches Deep Learning Intelligent Assistant (DaLIA) to Solve Clinical Development Pain Points

AI-Informed Virtual Assistant Elevates Functionality of Existing Clinical Trial Solutions CAMPBELL, CA – (June 11, 2018) – Saama Technologies, Inc., a leading data analytics company, today announced the launch of a unique set of Artificial Intelligence (AI) capabilities specifically designed to alleviate the planning, feasibility and conduct challenges inherent in and pervasive throughout the drug…

Read More

Dr. Ajit Shetty, Innovative Chairman Behind Janssen Pharmaceutical’s Global Transformation, Joins Saama’s Board of Directors

CAMPBELL, CA – (June 4, 2018) – Saama Technologies, Inc., a leading data analytics company, today announced that life sciences industry veteran and respected operational authority Ajit Shetty, Ph.D., has joined the company’s Board of Directors. Dr. Shetty brings significant enterprise-wide supply chain and management experience from over four decades at Fortune 100 pharmaceutical companies,…

Read More

Related Posts